The management of Type 2 Diabetes (T2D) is complex and challenging.

Sodium glucose cotransporter 2 (SGLT2) inhibition offers a different mode of action from other oral glucose lowering treatments.

Find out more about SGLT2 inhibition and its potential impact on T2D management.